Event June 11, 2026

The new era of the consumer - Deutsche Bank's dbAccess Global Consumer Conference 2026

global-consumer-stage2

Each year, Deutsche Bank’s dbAccess Global Consumer Conference brings together companies, investors, and industry leaders shaping the future of the consumer sector. The 23rd edition of the conference, held over three days last week, convened more than 120 leading companies with a combined market capitalisation of over $5 trillion and more than 1,000 senior decision-makers and attendees, spanning food and beverage, household and personal care, tobacco, and beauty. Deutsche Bank's leadership in the global consumer industry is built on our unique ability to convene its most influential players. The dbAccess Global Consumer Conference is our premier platform for doing just that, connecting leading corporate management teams with key institutional investors. This creates a powerful ecosystem that strengthens client relationships, drives strategic business opportunities across the bank, and provides a real-time pulse on the future of the sector.

The conference serves as a real-time pulse-check on the direction of the sector, capturing how management teams are adapting to shifting consumer priorities and the next wave of growth drivers.

“It was a privilege to host such a high calibre of consumer leadership teams and investors over three days in Paris last week. The industry is navigating a period of heightened volatility, shaped by a challenging macroeconomic backdrop, rapidly evolving consumer behaviours, a reversal of globalisation trends, and the need to adapt to an increasingly AI-driven world. It was fascinating to hear how companies are responding to these challenges head-on.”
Siddharth-Malik2
Siddharth Malik, Global Co-Head of Consumer and Retail Investment Banking, Deutsche Bank

The message from this year’s conference was clear: consumer demand remains resilient, but growth is becoming more selective and less reliant on pricing. The tone was constructive, with demand holding up better than feared and greater emphasis on value, mix, innovation, AI, category exposure, and share gains as drivers of outperformance.

“It is clear that volume-led top-line growth is the number one health indicator for consumer companies.”
Alex-Hecker2
Alex Hecker, Global Co-Head of Consumer and Retail Investment Banking, Deutsche Bank

While geopolitical and cost headwinds were generally viewed as manageable, input costs remain an important consideration for the second half of the year. This is prompting companies to focus more closely on balancing accessible entry points with premium propositions, using product newness, brand strength, and sharper execution to sustain demand.

Five recurring trends from the Global Consumer Conference:

Channel execution emerges as a key growth differentiator

The evolution of consumer channels is no longer a simple offline-versus-online debate. Companies now need to manage a more complex mix of consumer touchpoints across discovery, engagement, and conversion, with success increasingly dependent on balancing physical retail, e-commerce, social commerce, and online-led marketing.

This has important implications for growth and profitability. A stronger presence across channels can improve brand visibility, tailor product assortment and pricing structure, and enable faster responses to changing consumer behaviour.

Winning in channels is less about substitution and more about integration. Companies that can connect digital engagement with strong retail execution are better positioned to protect brand relevance, improve conversion, and capture demand as consumer journeys become less linear.

Input cost pressures and supply chain resilience remain front of mind

Cost pressures are moving back into focus, placing renewed emphasis on supply chain management as companies prepare for a potentially more challenging second half of the year. While there are no immediate signs of availability issues, energy, freight, and raw materials are becoming more visible pressure points, with hedging delaying rather than fully eliminating potential impacts.

“Commodity and margin headwinds remain real but are being framed as manageable through self-help (i.e. productivity, procurement, mix, pricing, scale).”
Steve-Powers2
Steve Powers, Head of US Consumer Packaged Goods Research, Deutsche Bank

The Middle East was also discussed through a more cautious lens, with freight costs emerging as the most immediate route through which pressures could reach consumers over time. Against this backdrop, flexible sourcing and strong operational execution are becoming increasingly critical to sustaining margin resilience.

AI adoption moves from productivity to value-chain integration

AI has moved beyond experimental use cases and is increasingly being deployed at scale across consumer companies, although adoption remains at different stages of maturity. For some, AI remains more focused on foundational productivity applications, while others have broadened its use to drive topline growth through more advanced consumer engagement and tailored marketing.

At the leading edge, however, companies are deploying AI across the value chain to better inform decision-making across innovation, pricing, and supply chain. With greater scale, richer consumer datasets, and stronger investment capacity, these companies are better positioned to operationalise AI end-to-end, translating its potential into tangible productivity and innovation gains – potentially widening the gap relative to their smaller or less digitally mature competitors.

global-consumer-setup

Health and wellness reshape consumer priorities, with GLP-1 as a catalyst

Consumers are becoming more deliberate in how they eat, shop, and allocate their spending, with a greater emphasis on nutritional efficiency, functionality, and portion control.

GLP-1 medication1 remains an important emerging watchpoint, particularly for food, beverage, and snacking categories where the read-across is most direct, but it is only part of a broader health and wellness shift. This is reflected in growing demand for protein and gut health, as well as more targeted consumer messaging around satiety and overall wellbeing.

Companies exposed to health-oriented nutrition, functional beverages, and fresh food are better placed to capture shifting consumer spend, while more traditional packaged food, indulgent, or discretionary categories may face greater scrutiny around long-term growth.

As priorities shift towards health and wellness, companies will need to adapt product portfolios and category mix, rather than solely relying on a stronger macroeconomic environment.

Disciplined capital allocation and targeted M&A

Capital allocation across the sector remains disciplined, reflecting a renewed focus on financial prudence, leverage discipline, and returns on capital.

“Investor focus has shifted toward integration risk, synergy delivery, and balance-sheet capacity. In other words, the market is giving little credit to strategic fit alone, with value to ultimately be dependent on execution and preserved financial flexibility.”
Steve Powers, Head of US Consumer Packaged Goods Research, Deutsche Bank

This is reinforcing a preference for selective, value-accretive transactions over large-scale transformative deals, with companies using M&A to reinforce category leadership, strengthen capabilities, access innovation, improve growth quality, and enhance margins.

“Despite obvious political headwinds, it is clear that global consumer companies still need to win in the US, and this will continue to drive cross-border M&A.”
Alex Hecker, Global Co-Head of Consumer and Retail Investment Banking, Deutsche Bank

This discipline is also visible internally. Companies are increasingly using portfolio optimisation, selective divestitures, and capital redeployment to sharpen strategic priorities and reinvest in champion brands, innovation, and commercial execution.

The common thread is that, rather than purely pursuing scale, management teams are placing greater emphasis on margins and returns, prioritising assets and initiatives that can enhance profitability, improve earnings visibility, and lift returns on capital.



1GLP-1 stands for Glucagon-Like Peptide-1, a hormone naturally produced in your intestines after you eat. It plays important role in regulating blood sugar, appetite, and digestion. GLP-1 medications are drugs developed by scientists that mimic the effects of natural GLP-1.



Further links on the topic

US CPG: Paris Takeaways 2026

dbAccess Global Consumer Conference: Key Equity Strategy Takeaways

European Consumer Staples: Global Consumer Conference - Key themes for European Staples




IMPORTANT NOTICE

By accepting these materials, the recipient shall be deemed to have agreed to the provisions and limitations set out in this notice.

These materials have been prepared by representatives of the Investment Banking division of Deutsche Bank AG or, as the case may be, any of its affiliates (as applicable, “DB”) and represent only the views and opinions of the individual authors. They have not been reviewed, endorsed, or otherwise approved by, and are not a work product of, any other department or division of DB, including the Research Department. These materials are intended merely to highlight aspects of the relevant conference to which they relate, are for general information purposes only and are intended only for use by the recipient for his/her own personal reference.  These materials are solely distributed by the relevant DB entities that possess the necessary licenses to distribute the materials in the respective jurisdictions (and shall not otherwise be intended for distribution).  These materials are being directed at persons who are professionals and are not intended for retail customer use. Not all products or services that may be mentioned in the materials are available in all jurisdictions.  In any event, no offers, sales, resales, or delivery of any products or services as may be described herein or any materials relating to any such products or services may be made in or from any jurisdiction except in circumstances which would result with compliance with any applicable laws and regulations and which would not impose any obligations on DB. DB has not acted (and does not purport to act in any way) in a fiduciary capacity. These materials are not intended to be comprehensive and do not constitute financial, investment, legal, regulatory, accounting, actuarial, tax or other advice, nor do they constitute an offer or solicitation for the purchase or sale of any financial instrument or to enter into any other agreement or a recommendation for any investment product or strategy.  The recipient must make their own independent assessment and such investigation as the recipient deems necessary in relation to the matters set out herein. No reliance should be placed upon these materials in connection with any actual transaction or investment. These materials speak only as of their date, and any views expressed in these materials are based upon conditions as they exist and are, therefore, subject to change. Any such changes and/or events occurring after the date of these materials could materially affect the content and views set out in these materials. These materials do not purport to contain a complete description of the matters set out herein. The analyses contained in these materials are not, and do not purport to be, appraisals of the assets, stock or business of any person.  These materials may not be summarized or otherwise reproduced, distributed or referred to, in whole or in part, without the prior written consent of DB. The information used in preparing these materials was obtained from sources believed to be reliable, but DB does not assume any responsibility for the independent verification of any such information and has relied on such information being complete and accurate in all material respects. DB makes no representation or warranty, express or implied, with respect to the fairness, correctness, accuracy, reasonableness or completeness of such information, these materials (including any opinion contained in these materials), any of their contents or any of the results that can be derived from these materials and no responsibility or liability is accepted by DB in relation to such materials including (without limitation): (i) in relation to the distribution of possession of these materials in any jurisdiction; (ii) for any loss or damage of any kind whatsoever arising as a result of the use or misuse of these materials; (iii) for updating or revising these materials; or (iv) for correcting any inaccuracy in these materials. Analyses and opinions contained in these materials may be based on assumptions that, if altered, could materially change the analyses or opinions expressed. No audit of these materials has been undertaken by an independent third party. Any statement, estimate or projection included in these materials (or upon which any of the conclusions contained in these materials are based) with respect to anticipated future performance may prove not to be correct. No representation or warranty, express or implied, is given as to the completeness or accuracy of any forward-looking statement contained in these materials or the accuracy of any of the underlying assumptions. Information about past performance is given for illustrative purposes only and should not be relied upon and is not an indication of future performance. DB has not verified the achievability of any estimate or forecast, nor of any of the methods underlying the preparation of any estimate or forecast. The products and investments mentioned in these materials are subject to investment risk, including (without limitation) market fluctuations, regulatory change, counterparty risk, possible delays in repayment and loss of income and principal invested. The value of investments can fall as well as rise and an investor may not get back the amount originally invested at any point in time. No assurance can be given that any investment described herein would yield favourable investment results.  DB may engage in transactions in a manner inconsistent with any views set out herein. DB trades or may trade as principal in any instruments mentioned herein (or related derivatives), may have proprietary positions in these instruments (or related derivatives) and/or may make a market in these instruments (or related derivatives) or (amongst other things) provide advice or loans or other financial products to, or participate in any underwriting or restructuring or other transactions with or in respect of persons mentioned herein. Deutsche Bank AG is a stock corporation (Aktiengesellschaft) incorporated under the laws of the Federal Republic of Germany with its principal office in Frankfurt am Main. It is registered with the local district court (Amtsgericht) in Frankfurt am Main under No HRB 30000 and licensed to carry on banking business and to provide financial services. The London branch of Deutsche Bank AG is registered as a branch office in the register of companies for England and Wales at Companies House (branch registration number BR000005) with its registered branch office address and principal place of business at 21, Moorfields, London EC2Y 9DB. Deutsche Bank AG is subject to supervision by the European Central Bank (ECB), Sonnemannstrasse 22, 60314 Frankfurt am Main, Germany, and the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht or BaFin), Graurheindorfer Strasse 108, 53117 Bonn and Marie-Curie-Strasse 24-28, 60439 Frankfurt am Main, Germany. With respect to activities undertaken in the United Kingdom, Deutsche Bank AG is authorised by the Prudential Regulation Authority. It is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of Deutsche Bank AG’s authorisation and regulation by the Prudential Regulation Authority are available from Deutsche Bank AG on request.

How helpful was this article?

Click on the stars to send a rating

Successful